ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) is a clinical-stage biopharmaceutical company that discovers and develops therapies ...
Aurora Innovation Inc. (NASDAQ: AUR) is one of the stocks that will double in 2026. On December 9, Itay Michaeli from TD ...
In other news, earlier in its Q3 2025 earnings report, UniQure detailed promising clinical data for its lead gene therapy ...
Amdocs Limited (NASDAQ:DOX) is one of the best affordable AI stocks to buy now. Amdocs Limited (NASDAQ:DOX) commands a ...
Evolent Health Inc. (NYSE: EVH) is one of the stocks that will double in 2026. On November 21, Citi lowered the firm’s price ...
By hosting the platform entirely within South Africa, NICE ensures that applications and customer data remain in-country, ...
Next up, I like Thursday… After the close is the biggest night of the week when CNBC Investing Club position, Nike reports, ...
In Q3 2025, Viking Therapeutics highlighted significant progress in its obesity pipeline, particularly for the dual GLP-1/GIP ...
Earlier in its Q3 2025 earnings report, Evolus achieved global net revenue of $69 million, which marked a 13% increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback